Exact Mass: 426.1966

Cariprazine

C21H32Cl2N4O (426.1953)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Cariprazine is a novel antipsychotic agent candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).

1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4,5,6-tetrahydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one

11,13-Dihydrotaraxinic acid glucosyl ester

(2R,3R,4S,5R,6R)-2,3,5-Trihydroxy-6-(hydroxymethyl)oxan-4-yl (3as,11as)-3,10-dimethyl-2-oxo-2H,3H,3ah,4H,5H,8H,9H,11ah-cyclodeca[b]furan-6-carboxylic acid

Constituent of Taraxacum officinale (dandelion). 11,13-Dihydrotaraxinic acid glucosyl ester is found in many foods, some of which are tea, alcoholic beverages, coffee and coffee products, and dandelion. 11,13-Dihydrotaraxinic acid glucosyl ester is found in alcoholic beverages. 11,13-Dihydrotaraxinic acid glucosyl ester is a constituent of Taraxacum officinale (dandelion)

(2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate

(2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulphonic acid

Gemfibrozil 1-O-beta-Glucuronide

6-{[5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

Iloperidone

1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone

C24H27FN2O4 (426.1955)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].

MEK inhibitor

3-[({3-[(dimethylamino)methyl]phenyl}imino)(phenyl)methyl]-2-hydroxy-N-methyl-1H-indole-6-carboximidate

Ripisartan

5-methyl-7-propyl-8-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-2H,3H-[1,2,4]triazolo[1,5-c]pyrimidin-2-one

C23H22N8O (426.1916)

10-Hydroxy-1betaH-lycoserone

Sonchuside E

[3aS-(3aalpha,5abeta,6beta,9alpha,9aalpha,9bbeta)]-6-(beta-D-Glucopyranosyloxy)dodecahydro-5a-methyl-3-methylene-2-oxonaphtho[1,2-b]furan-9-carboxaldehyde

Kushenol T

(2S) -5,7,2-Trihydroxy-8- (5-hydroxy-2-isopropenyl-5-methylhexyl) flavanone

Rhinacanthin H

Diaspanoside C

Broussoflavan A

(2S) -3,3,4,4-Tetrahydro-2,2-dimethyl-7- (3-methyl-2-butenyl) -2,6-bi [ 2H-1-benzopyran ] -3,4,7,8-tetrol

Lanceocrepidiaside A

Pteroside X

Drimanial

Andibenin B

Rhinacanthin G

naucleidinal

fr901483

C20H31N2O6P (426.192)

Cochliobolic acid

10-Hydroxycyclolycoserone

(-)-Ixerin J

10-Hydroxyisolycoserone

Notoptolide

Macrocliniside H

3-Geranyl-4,2,4,5,6-pentahydroxydihydrochalcone

4,2,3,4,6-Pentahydroxy-5-neryldihydrochalcone

2,4,6,3,4-Pentahydroxy-3,5-diprenyldihydrochalcone

2,4,6,3,4-Pentahydroxy- 3,5-diprenyldihydrochalcone

MCULE-2704123094

(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

(+)-3,4-(6,6-dimethyldihydropyrano)-4,5-[2-(1-hydroxy-1-methylethyl)-dihydrofurano]-2,3-dihydroxydihydrochalcone|bartericin C

CHEMBL3593935

Neoaustin

onitioside A

Antibiotic 49A

3-O-beta-D-glucopyranosyl-3beta,14-dihydroxycostunolide

hesseltin C

1,8-dihydroxy-3-(3,7-dimethyl-7-methoxyoct-2-enyloxy)-6-methyl xanthone

7beta-O-beta-glucopyranosyl bombaxone|7beta-O-beta-glucopyranosyl-10beta-hydroxy hibiscone B

Ixerisoside E

1beta-O-((E)-p-methoxycinnamoyl)-6alpha-hydroxypolygodial|1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxypolygodial|isodrimanial

prenantheside A

ammodoremin

10beta,14-dihydroxy-10(14),11beta(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin C-10-O-beta-glucopyranoside

1-[3-(6,7-dihydroxy-3,7-dimethyloct-2-enyl)-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one

8beta-hydroxy-4alpha,15-dihydrozaluzanin C-3-O-beta-glucopyranoside

C21H30O9

(1R,5R,6R,7S,9R)-6,9alpha-epoxy-9,15-bisabolanolide-5-O-beta-D-glucopyranoside|abiespiroside A

Hyuganoside II

boropinan

(3S)-3-hydroxyatractylenolide III 3-O-beta-D-glucopyranoside|(3S)-3-Hydroxyatractylenolide III 3-O-??-D-glucopyranoside|(3S,5R,8R,10R)-3,8-dihydroxyeudesma-4(15),7(11)-diene-8,12-olide 3-O-beta-D-glucopyranoside

(3S)-3-hydroxyatractylenolide III 3-O-beta-D-glucopyranoside|(3S)-3-Hydroxyatractylenolide III 3-O-??-D-glucopyranoside|(3S,5R,8R,10R)-3,8-dihydroxyeudesma-4(15),7(11)-diene-8,12-olide 3-O-beta-D-glucopyranoside

cynarascoloside C|isoamberboin 8-O-beta-D-glucopyranoside

Ardeemin

hesseltin D

isoaustinone

bruceine F

dicitrinol A

C25H30O6

4alpha-O-beta-D-glucopyranosyl-15-hydroxyl-5alpha,6betaH-guaiane-10(14),11(13)-dien-12,6alpha-olide

insuetolide C

illihenlactone F

(2R,3R)-7,4-dihydroxy-6-(3-hydroxy-3-methylbutyl)-8-(3-methylbut-2-en-1-yl)dihydroflavonol

13,17-epoxy-1beta,11beta,12alpha,14beta,15beta-pentahydroxy-2alpha-methoxypicras-3-en-16-one|bruceine M

SCHEMBL19004034

myristicyclins A

11beta,13-dihydrocrepiside C

dorsmanin J

Epipterosin L 2-O-glucoside

11,13-dihydro-taraxinic acid 14-O-beta-D-glucoside|11,13-Dihydro-Taraxinsaeure-1-O-beta-D-Glucopyranosid|11,13-dihydrotaraxinic acid-beta-glucopyranosyl ester|11beta,13-dihydrotaraxinic acid beta-glucopyranosyl ester|11??,13-Dihydro-taraxinic acid-1-O-??-D-glucopyranoside

11,13-dihydro-taraxinic acid 14-O-beta-D-glucoside|11,13-Dihydro-Taraxinsaeure-1-O-beta-D-Glucopyranosid|11,13-dihydrotaraxinic acid-beta-glucopyranosyl ester|11beta,13-dihydrotaraxinic acid beta-glucopyranosyl ester|11??,13-Dihydro-taraxinic acid-1-O-??-D-glucopyranoside

1(10)E-4Z-3alpha-hydroxy-germacra-1(10),4,11(13)-trien-6,12-olide-14-O-beta-D-glucopyranoside

SCHEMBL15386088

11beta,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|11beta,13-dihydrodesacylcynaropicrin-8-beta-D-glucoside|11betaH-11,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|3beta-hydroxy-11beta,13-dihydro-8alpha-O-beta-D-glucozaluzanin C

11beta,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|11beta,13-dihydrodesacylcynaropicrin-8-beta-D-glucoside|11betaH-11,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|3beta-hydroxy-11beta,13-dihydro-8alpha-O-beta-D-glucozaluzanin C

(2R,3R)-pterosin L 3-O-beta-D-glucopyranoside|2R,3R-pterosin L 3-O-beta-D-glucopyranoside

Ecklonochinon A|Ecklonochinon B|Ecklonoquinone B

Doremone A

3beta,6beta-Bis-(angeloyloxy)-9-oxoeuryopsin

2,4,6,3,4-Pentahydroxy- 3,5-diprenyldihydrochalcone

Diethylfuroguaiacidin

Cratoxylone

salignoside

Ecklonochinon A|Ecklonochinon B|Ecklonoquinone A

2beta-hydroxysantamarine-1beta-D-glucopyranoside

2-Methylbutanoic acid 3-[2-(3,4-dimethoxyphenyl)-7-methoxybenzofuran-5-yl]propyl ester

fukanedone E|rel-3(S)-(2-hydroxy-4-methoxybenzoyl)-4(R),5(R)-dimethyl-5-[4-methyl-5-(4-methyl-2-furyl)-3(E)-penten-1-yl]tetrahydro-2-furanone

15-glucopyranosyloxy-2-oxo-guai-3-en-1alpha,5alpha,6beta,7a,10alpha,11betaH-12,6-olide

ixerin J

4alpha-hydroxy-5alpha,8betaH-lindan-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside G

(-)-1,2,5-triangelyl-d- (or l)-inositol

cis-1,2,3,5-trans-4,6-inositol-2,3,6-triangelate

alpha,3,4,2,4-Pentahydroxy-5,3-diprenyl-alpha,beta-dihydro-trans-chalcone

SCHEMBL13794916

2-[6-hydroxy-3,7-dimethylocta-2(E),7-dienyl]-2,3,4,4-tetrahydroxydihydrochalcone

SCHEMBL910058

SCHEMBL11569654

Phe Phe Asn

Arg Asp His

Asp Arg His

Arg His Asp

Phe Asn Phe

Feruloyl putrescine O-hexoside

C20H30N2O8 (426.2002)

ABA-GE cpd

1-O-{(2Z,4E)-5-[(1S)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoyl}-beta-D-glucopyranose

(+)-abscisic acid beta-D-glucopyranosyl ester is a (+)-abscisic acid D-glucopyranosyl ester that is derived from beta-D-glucopyranose. It is functionally related to a (+)-abscisic acid and a beta-D-glucose. (+)-abscisic acid beta-D-glucopyranosyl ester is a natural product found in Salacia chinensis, Arabidopsis thaliana, and other organisms with data available. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

Iloperidone (Fanapt)

C24H27FN2O4 (426.1955)

8-(2,4-dihydroxy-6-pentylphenoxy)-6-hydroxy-3-pentylisochromen-1-one

NCGC00381021-01!8-(2,4-dihydroxy-6-pentylphenoxy)-6-hydroxy-3-pentylisochromen-1-one

[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate

NCGC00347810-02![5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate

C21H30O9_Azuleno[4,5-b]furan-2(3H)-one, 8-(beta-D-glucopyranosyloxy)decahydro-6-hydroxy-6-methyl-3,9-bis(methylene)-, (3aS,6R,6aR,8S,9aR,9bS)

NCGC00385793-01_C21H30O9_Azuleno[4,5-b]furan-2(3H)-one, 8-(beta-D-glucopyranosyloxy)decahydro-6-hydroxy-6-methyl-3,9-bis(methylene)-, (3aS,6R,6aR,8S,9aR,9bS)-

[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate

[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate_major

Phe Phe Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]acetamido}acetic acid

Phe Gly Gly Phe

(2S)-2-(2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}acetamido)-3-phenylpropanoic acid

Gly Phe Phe Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-phenylpropanamido]acetic acid

Gly Phe Gly Phe

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]acetamido}-3-phenylpropanoic acid

Gly Gly Phe Phe

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-phenylpropanamido]-3-phenylpropanoic acid

Asp His Arg

Asn Phe Phe

His Arg Asp

His Asp Arg

Win 55212-2

A organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole substituted at position 6 by a 1-naphthylcarbonyl group. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

gamma-CEHC Glc

gamma-carboxyethyl-hydroxychroman beta-D-glucoside

Dolichyl phosphate D-mannose

C18H35O9P (426.2019)

Phe Gly Phe Gly

2-[[2-[[2-[(2-amino-3-phenylpropanoyl)amino]acetyl]amino]-3-phenylpropanoyl]amino]acetic acid

11,13-Dihydrotaraxinic acid glucosyl ester

(2R,3R,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl (3aS,11aS)-3,10-dimethyl-2-oxo-2H,3H,3aH,4H,5H,8H,9H,11aH-cyclodeca[b]furan-6-carboxylate

(±)-WIN 55,212

3-Hydroxylidocaine glucuronide

C20H30N2O8 (426.2002)

SCH-1473759

C20H26N8OS (426.195)

2-acetamido-3-o-benzyl-4,6-o-benzylidene-2-deoxy-beta-d-glucopyranosyl azide

Losartan D4

C22H19D4ClN6O (426.1873)

Ripisartan

5-methyl-7-propyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-[1,2,4]triazolo[1,5-c]pyrimidin-2-one

C23H22N8O (426.1916)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist

Onitisin 2-O-glucoside

H-D-Arg(Pbf)-OH

C19H30N4O5S (426.1937)

Methanesulfonamide, N-(3-(3-((2,3-dihydro-2-hydroxy-1H-inden-2-yl)methyl)-6-ethyl-3-azabicyclo(3.1.0)hex-6-yl)phenyl)-

Cyanocycline A

Methanone, (2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, (S)-

L-Asparaginyl-L-phenylalanyl-L-phenylalanine

Iloperidone

C24H27FN2O4 (426.1955)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].

8-(2,4-Dihydroxy-6-pentylphenoxy)-6-hydroxy-3-pentylisochromen-1-one

(1S,12R,23R)-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetrazahexacyclo[12.10.0.02,11.04,9.015,23.017,22]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione

andilesin D

5-methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione

C20H25F3N4O3 (426.1879)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

Ftidkiazunxncj-wbyqcalvsa-

Chrodrimanin E

(+)-abscisic acid D-glucopyranosyl ester

(S)-2-trans-abscisic acid beta-D-glucopyranosyl ester

An (S)-2-trans-abscisic acid D-glucopyranosyl ester derived from beta-D-glucopyranose.

chrodrimanin T

1-O-[(2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoyl]-D-glucopyranose

2-Nonadioyl-sn-glycero-3-phosphocholine

C17H33NO9P- (426.1893)

Asp-Arg-His

Arg-His-Asp

Arg-Asp-His

His-Arg-Asp

His-Asp-Arg

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

[(2S,3R)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide

N,N-dimethyl-4-[4-[(1R,5S)-3-[oxo(2-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide

[(2S,3S)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol

[(2R,3R)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol

Phe-Asn-Phe

Asp-His-Arg

Phe-Phe-Asn

(S)-2-trans-abscisic acid D-glucopyranosyl ester

A carboxylic ester that results from the condensation of the carboxylic acid group of (S)-2-trans-abscisic acid with the anomeric hydroxy group of D-glucopyranose.

3-(4-hydroxyphenyl)-1-[2,4,6-trihydroxy-3-[(2Z)-3-(hydroxymethyl)-7-methylocta-2,6-dienyl]phenyl]propan-1-one

2-trans-abscisic acid D-glucosyl ester

An enoate ester that results from the condensation of the carboxylic acid group of 2-trans-abscisic acid with the anomeric hydroxy group of D-glucopyranose.

Asn-Phe-Phe

ST 25:7;O6

Etrumadenant

C23H22N8O (426.1916)

Etrumadenant (AB928) is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. Etrumadenant relieves adenosine-mediated immune suppression. Etrumadenant has immunomodulatory and antitumor activities[1][2].

His-[D-2-ME-Trp]-Ala

C21H26N6O4 (426.2015)

His-[D-2-ME-Trp]-Ala is a fragment of the growth hormone hexarelin.

3-hydroxy-3-methyl-6,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-2,3,5,8-tetrahydro-1h-naphthalen-1-yl 3-(4-methoxyphenyl)prop-2-enoate

3,10-dimethyl-2-oxo-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde

2-(3,3-dimethylbutyl)-1,3,6-trihydroxy-7-methoxy-8-(3-methylbut-2-en-1-yl)xanthen-9-one

(2r,3r)-6-(2-hydroxyethyl)-2-(hydroxymethyl)-2,5,7-trimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h-inden-1-one

(3r,3ar,6ar,8s,9ar,9br)-3-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

(1s,5s,10r)-5-(3,4-dihydroxyphenyl)-9-hydroxy-13,13-dimethyl-2-(3-methylbut-2-en-1-yl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-2,8-dien-7-one

5a-methyl-3-methylidene-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-9-carbaldehyde

3-methyl-2-oxo-10-{[(3,4,5-trihydroxy-6-methoxyoxan-2-yl)oxy]methyl}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde

4-hydroxy-3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one

(1s,4r,10s,11s,15s)-5,5,10,13,15-pentamethyl-6,19,22-trioxahexacyclo[13.7.1.0¹,¹¹.0⁴,¹⁰.0¹³,²¹.0¹⁷,²¹]tricosa-8,16-diene-7,14,18-trione

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3s,3as,11as)-3,10-dimethyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate

(1r,4ar,8r,8as)-7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-2,3,5,8-tetrahydro-1h-naphthalen-1-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

4-[(1s,3ar,4s,6ar)-4-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol

(3as,5ar,6s,7r,9as,9bs)-7-hydroxy-5a,9-dimethyl-3-methylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-2-one

(2s,3r)-5-hydroxy-2-(2-hydroxypropan-2-yl)-3-[(3s)-3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxin-5-yl]-2,3-dihydro-1h-indene-4-carbaldehyde

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 5-(2,3-dimethyloxiran-2-yl)-2-methylpent-2-enoate

(3as,6r,6ar,8s,9ar,9bs)-6-hydroxy-6-methyl-3,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

(2r)-2-[(2s,3s)-8-methyl-3-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,5,6,7-hexahydronaphthalen-2-yl]propanoic acid

(2s)-4-hydroxy-6-(2-hydroxyethyl)-2,5,7-trimethyl-2-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h-inden-1-one

6-(hydroxymethyl)-3-methyl-9-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,6ah,7h,8h,9ah,9bh-azuleno[4,5-b]furan-2-one

9-hydroxy-9-methyl-3,6-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

3-methyl-5-(2,6,6-trimethyl-4-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-2-en-1-yl)penta-2,4-dienoic acid

(1r,3r,4s,9s,16s,18s,19r,21s)-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile

(1r,3r,4s,9s,16s,18s,19r,21s)-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile

3-{[(3r,3as,4s)-3-hydroxy-3-[(1s)-1-hydroxy-2-methylpropyl]-1,4-dimethyl-2-oxo-5,6-dihydro-4h-pentalen-3a-yl]methyl}-4-hydroxy-5-methylchromen-2-one

(3s,3as,9r,11as)-3,10-dimethyl-2-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde

11'-hydroxy-2,2,2',9',12'-pentamethyl-6',15'-dimethylidene-13'-oxaspiro[pyran-3,5'-tetracyclo[7.5.1.0¹,¹¹.0²,⁷]pentadecane]-6,10',14'-trione

10β,14-dihydroxy-10(14),11β(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin c10-o-β-d-glucopyranoside

{"Ingredient_id": "HBIN000060","Ingredient_name": "10\u03b2,14-dihydroxy-10(14),11\u03b2(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin c10-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2C=CC(C3CCC(=C)C3C2OC1=O)(CO)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6142","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6α)-form,11,13-dihydro,beta-d-glucopyranosyl ester

{"Ingredient_id": "HBIN000218","Ingredient_name": "1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6\u03b1)-form,11,13-dihydro,beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9728","PubChem_id": "NA","DrugBank_id": "NA"}

11β,13-dihydrotaraxinic acid

{"Ingredient_id": "HBIN000361","Ingredient_name": "11\u03b2,13-dihydrotaraxinic acid","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CCC(=CCCC(=CC2OC1=O)C)C(=O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41594","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

11β,13-dihydro-taraxinicacid-1'-o-β-d-glucopyranoside

{"Ingredient_id": "HBIN000362","Ingredient_name": "11\u03b2,13-dihydro-taraxinicacid-1'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2C(CC(=C)C3CC(C(=C)C3C2OC1=O)O)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5723","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

11β,13-dihydrotaraxinic acid β-glucopyranosyl ester

{"Ingredient_id": "HBIN000363","Ingredient_name": "11\u03b2,13-dihydrotaraxinic acid \u03b2-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CCC(=CCCC(=CC2OC1=O)C)C(=O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41595","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2r,3r-pterosin l-2'-o-β-d-glucoside

{"Ingredient_id": "HBIN006457","Ingredient_name": "2r,3r-pterosin l-2'-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18126","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2s,3r-pterosin l-2'-o-β-d-glucoside

{"Ingredient_id": "HBIN006686","Ingredient_name": "2s,3r-pterosin l-2'-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18127","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(3s)-3-hydroxyatractylenolide iii3-o-β-d-glucopyranoside

{"Ingredient_id": "HBIN009613","Ingredient_name": "(3s)-3-hydroxyatractylenolide iii3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1=C2CC3C(=C)C(CCC3(CC2(OC1=O)O)C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9805","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

9α-hydroxy-11β,13-dihydrozaluzanin c3-o-β-allopyranoside

{"Ingredient_id": "HBIN014042","Ingredient_name": "9\u03b1-hydroxy-11\u03b2,13-dihydrozaluzanin c3-o-\u03b2-allopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CC(C(=C)C3CC(C(=C)C3C2OC1=O)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10011","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

1,8-dihydroxy-3-[(7-methoxy-3,7-dimethyloct-2-en-1-yl)oxy]-6-methylxanthen-9-one

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoate

1-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4,5,6-tetrahydroxyphenyl}-3-(4-hydroxyphenyl)propan-1-one

(2r,4s,4ar,8r,8ar)-4,4',7-trimethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,4a,5,8,8a-hexahydrospiro[1-benzopyran-2,2'-furan]-5'-one

(3s,3as,5r,6ar,8s,9ar,9bs)-5-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

(2r,3r,5s)-3-hydroxy-5-[(1e,3e,5e,7e,9e,11e,15e)-17-methyl-13,14-dioxononadeca-1,3,5,7,9,11,15-heptaen-1-yl]oxolane-2-carboxylic acid

(2r,3s)-2-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4,5-dihydroxyphenyl}-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(1r,4as,5s,8r,8as)-7,8-diformyl-5-hydroxy-4,4,8a-trimethyl-1,2,3,4a,5,8-hexahydronaphthalen-1-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

(2z,4e)-3-methyl-5-[(1s)-2,6,6-trimethyl-4-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-2-en-1-yl]penta-2,4-dienoic acid

5-(3,4-dihydroxyphenyl)-9-hydroxy-13,13-dimethyl-2-(3-methylbut-2-en-1-yl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-2,8-dien-7-one

1-(3,3-dimethylbutyl)-3,6,8-trihydroxy-2-methoxy-7-(3-methylbut-2-en-1-yl)xanthen-9-one

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl (2e,6r)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

(3s,3as,9s,11as)-3,10-dimethyl-2-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde

aba-β-ge

9-hydroxy-10-methyl-3-methylidene-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

(3s,3as,5r,6ar,8s,9ar,9bs)-5-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl (2e,7r)-7-hydroxy-2-methyl-6-methylideneoct-2-enoate

5-hydroxy-3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one

(1s,12r,15s,23r)-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione

(1r,7s,9s,10r,12s,13r)-13-hydroxy-4,9-dimethyl-13-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-5-one

(3s,3ar,4r,6ar,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-2-one

3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-5-yl]propyl (2r)-2-methylbutanoate

2-[3-(3,4-dihydroxyphenyl)propoxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl 3-methylpent-2-enoate

(11r)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4,6,8(12)-tetraene

(4s,4ar,5r,6s)-3,4a,5-trimethyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-9-oxo-4h,5h,6h,7h-naphtho[2,3-b]furan-4-yl (2z)-2-methylbut-2-enoate

(1s,6r,14r,15s,17r,22s)-10,15-dihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11,20-tetraene-8,19-dione

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoate

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl (2e)-5-[(2r,3s)-2,3-dimethyloxiran-2-yl]-2-methylpent-2-enoate

(3s,3as,9s,11ar)-3,10-dimethyl-2-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde

6-hydroxy-6-methyl-3,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

7-hydroxy-5a,9-dimethyl-3-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-2-one

(3as,6r,6as,8r,9ar,9br)-6-hydroxy-6-methyl-3,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

(1'r,2'r,3s,9's,11's,12's)-11'-hydroxy-2,2,2',6',9',12'-hexamethyl-15'-methylidene-13'-oxaspiro[pyran-3,5'-tetracyclo[7.5.1.0¹,¹¹.0²,⁷]pentadecan]-6'-ene-6,10',14'-trione

5,5,10,13,15-pentamethyl-6,19,22-trioxahexacyclo[13.7.1.0¹,¹¹.0⁴,¹⁰.0¹³,²¹.0¹⁷,²¹]tricosa-8,16-diene-7,14,18-trione

(3s)-3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)-3-hydroxy-1-[(2s)-6-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]propan-1-one

3-[(1r,4as,7s,7ar)-3-[(2r)-2-hydroxy-3-methylbutanoyl]-4,7-dimethyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]-4-hydroxy-5-methylchromen-2-one

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl (2e)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

(3s,3as,5r,6ar,8s,9ar,9bs)-5-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)-3-hydroxy-1-[6-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]propan-1-one

2-methoxy-4-(4-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-hexahydrofuro[3,4-c]furan-1-yl)phenol

5'-ethenyl-2'-(4-hydroxy-6-methyl-3-oxohept-5-en-2-yl)-7-methoxy-5'-methylspiro[1-benzopyran-3,1'-cyclopentane]-2,4-dione

13-(2-hydroxy-3-methylbutanoyl)-9,14,18-trimethyl-4,12,20-trioxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁵,¹⁹]icosa-2(11),5,7,9-tetraen-3-one

(1s,13s,14r,15s,18s,19r)-13-[(2r)-2-hydroxy-3-methylbutanoyl]-9,14,18-trimethyl-4,12,20-trioxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁵,¹⁹]icosa-2(11),5,7,9-tetraen-3-one

(2r)-5,7-dihydroxy-8-[(2r)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl]-2-(2-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

(3r,3ar,4s,6ar,8s,9ar,9br)-8-hydroxy-3-methyl-6,9-dimethylidene-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl (2e)-7-hydroxy-2-methyl-6-methylideneoct-2-enoate

(4ar,6s,8ar,9as)-9a-hydroxy-3,8a-dimethyl-5-methylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one

11'-hydroxy-2,2,2',6',9',12'-hexamethyl-15'-methylidene-13'-oxaspiro[pyran-3,5'-tetracyclo[7.5.1.0¹,¹¹.0²,⁷]pentadecan]-6'-ene-6,10',14'-trione

4-hydroxy-3-[3-(2-hydroxy-3-methylbutanoyl)-4,7-dimethyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]-5-methylchromen-2-one

(1s,12r,23r)-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione

(3s,3as,5r,6ar,8s,9ar,9bs)-5-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

(3as,5ar,6r,9r,9as,9bs)-5a-methyl-3-methylidene-2-oxo-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-9-carbaldehyde

3-hydroxy-5-(1-hydroxyethenyl)-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl 3,4-dihydroxy-2-methylidenebutanoate

1,8-dihydroxy-3-{[(2e)-7-methoxy-3,7-dimethyloct-2-en-1-yl]oxy}-6-methylxanthen-9-one

(3as,9r,11ar)-6-(hydroxymethyl)-10-methyl-3-methylidene-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

(2e)-1-{3-[(2e,6s)-6,7-dihydroxy-3,7-dimethyloct-2-en-1-yl]-2,4-dihydroxyphenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one

(2r,3r)-5-hydroxy-2-(2-hydroxypropan-2-yl)-3-[(3s)-3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxin-5-yl]-2,3-dihydro-1h-indene-4-carbaldehyde

3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,6h,6ah,9ah,9bh-azuleno[4,5-b]furan-2,7-dione

(3as,5ar,6r,9r,9as,9bs)-5a-methyl-3-methylidene-2-oxo-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-9-carbaldehyde

[(1s,3s,6s,7s,8r,9s)-7-hydroxy-6-[(4-methoxyphenyl)methyl]-3-(methylamino)-5-azatricyclo[6.3.1.0¹,⁵]dodecan-9-yl]oxyphosphonic acid

C20H31N2O6P (426.192)

15-hydroxy-12,16,16-trimethyl-8-(penta-1,3-dien-1-yl)-3,9,11-trioxapentacyclo[10.7.1.0¹,¹⁵.0⁴,²⁰.0⁵,¹⁰]icosa-5(10),7-diene-6,17-dione

(3s,3ar,4s,6ar,8r,9ar,9br)-8-hydroxy-3-methyl-6,9-dimethylidene-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl (2e)-5-[(2s,3r)-2,3-dimethyloxiran-2-yl]-2-methylpent-2-enoate

(3as,6ar,8s,9s,9as,9bs)-9-hydroxy-9-methyl-3,6-dimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

3-{3,4-dihydroxy-2-[(2e,6r)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]phenyl}-1-(2,4-dihydroxyphenyl)propan-1-one

(3r,3as,6as,8r,9as,9bs)-3-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one

(3r,4s)-6-[(2s)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-2-yl]-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-3,4,8-triol

(1'r,2's,3r,7's,9'r,11'r,12's)-11'-hydroxy-2,2,2',9',12'-pentamethyl-6',15'-dimethylidene-13'-oxaspiro[pyran-3,5'-tetracyclo[7.5.1.0¹,¹¹.0²,⁷]pentadecane]-6,10',14'-trione

1,9-diisopropyl-4,6-dimethyl-7,8-dioxooxanthren-2-yl 3-methylbutanoate

6-(7-hydroxy-3,4-dihydro-2h-1-benzopyran-2-yl)-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-3,4,8-triol

16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile

(1s,3r,4r,9r,16r,18r,19s,21r)-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile

(1s,3r,4r,9r,16r,18r,19s,21r)-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile